guidance.fyi
Company, ticker, metric, guidance, or anything said

Concalls & earnings callsKrsnaa Diagnostics Limited

Every summarised call, newest first. Latest is Q1 FY27, held 14 Aug 2026.

Latest quarter

Q1 FY27 snapshot

Open full brief →

The quarter was driven by the transition of the large Rajasthan PPP project from infrastructure build-out to revenue generation, strong retail growth, and a new project win in Himachal Pradesh.

MetricThis quarterChangeFive-quarter trend
Revenue from Operations₹235.5 Cr22%
EBITDA₹58.8 Cr—
EBITDA Margin25%—
PAT₹16.6 Cr—
Latest guidance
  • Rajasthan full-year revenue guidance: INR 100-150 crores (conservative).
  • Retail business expected to be EBITDA positive by Q2 FY27.
  • Overall margins expected to improve and return to double digits by year-end.
  • Retail contribution target for the financial year: 10% to 15% of overall revenue.
Filed results

Reported quarterly history

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

QuarterRevenueNet profit (PAT)Basic EPS
Q3 FY25₹174.51 Cr+10.2% YoY-6.3% QoQ₹19.41 Cr+49.7% YoY-1% QoQ₹6.01+46.9% YoY-1% QoQ
Q2 FY25₹186.34 Cr+19.9% YoY+9.5% QoQ₹19.60 Cr+86.7% YoY+9.4% QoQ₹6.07+81.2% YoY+9.4% QoQ
Q1 FY25₹170.23 Cr+22% YoY+2.4% QoQ₹17.92 Cr+22.4% YoY-4.3% QoQ₹5.55+19.1% YoY-4.3% QoQ
Q4 FY24₹166.28 Cr+24.8% YoY+5% QoQ₹18.73 Cr-1% YoY+44.4% QoQ₹5.80-3.8% YoY+41.8% QoQ
Q3 FY24₹158.32 Cr+34.1% YoY+1.8% QoQ₹12.97 Cr-4.9% YoY+23.5% QoQ₹4.09-6% YoY+22.1% QoQ
Call history
  • Q1 FY27Positive tone

    The quarter was driven by the transition of the large Rajasthan PPP project from infrastructure build-out to revenue generation, strong retail growth, and a new project win in Himachal Pradesh.

    Revenue from Operations
    ₹235.5 Cr22%
    EBITDA
    ₹58.8 Cr
    Pharmaceuticals & HealthcareVerified brief4 guidance items